<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD006487-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD006487-sec-0029"></div> <div class="table" id="CD006487-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">4% articaine, 1:100,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>4% articaine, 1:100,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Brazil (n = 2), India (n = 1), and USA (n = 4)<br><b>Intervention:</b> 4% articaine, 1:100,000 epinephrine<br><b>Comparison:</b> 2% lidocaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% lidocaine, 1:100,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% articaine, 1:100,000 epinephrine</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of diseased pulps with irreversible pulpitis)</b><br> Absence of pain ('0' on a visual or verbal analogue scale. Scales of 0â3, 0â4, 0â10, and HeftâParker VAS)<br> Followâup: from 10 minutes post injection to end of the clinical procedure </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.6</b> <br> (1.1 to 2.32) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>203 participants, 203 interventions<br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported (estimated to be &lt; 1 hour)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>309 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>494 per 1000</b><br> (340 to 717) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>HeftâParker VAS (0â170 millimetres)</p> <p>Followâup: 0â1 minute following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean pain on injection in the lidocaine group was <b>34.92 mm</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean pain on injection in the articaine group was<br><b>4.74 mm higher</b><br> (1.98 mm lower to 11.46 mm higher) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>157 participants, 314 interventions<br> (3 studies) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>c</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>HeftâParker VAS (0â170 millimetres)</p> <p>Followâup: measured at the time anaesthesia wore off</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean pain following injection in the lidocaine group was <b>18.54 mm</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean pain following injection in the articaine group was <b>6.41 mm higher</b><br> (1.01 mm to 11.8 mm higher). </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>156 participants, 309 interventions<br> (3 studies) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>c</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Exact times of followâup not reported</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear risks of selection and detection bias).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">3% prilocaine, 0.03 IU felypressin compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>3% prilocaine, 0.03 IU felypressin compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Germany<br><b>Intervention:</b> 3% prilocaine, 0.03 IU felypressin<br><b>Comparison:</b> 2% lidocaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% lidocaine, 1:100,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>3% prilocaine, 0.03 IU felypressin</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain<br> Followâup: not reported </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.86</b> <br> (0.79 to 0.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>907 participants, 907 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported (estimated to be &lt; 2 hours)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>763 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>656 per 1000</b><br> (603 to 725) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear risk of attrition bias in one study, and both trials have unclear methods of randomization sequence generation and allocation concealment). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">4% articaine, 1:200,000 epinephrine compared with 4% articaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>4% articaine, 1:200,000 epinephrine compared with 4% articaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Brazil (n = 1), Germany (n = 2), and USA (n = 2; pain on injection/pain following injection and allergy)<br><b>Intervention:</b> 4% articaine, 1:200,000 epinephrine<br><b>Comparison:</b> 4% articaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% articaine, 1:100,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% articaine, 1:200,000 epinephrine</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain<br> Followâup: from 5 minutes post injection to end of the clinical procedure </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.85</b> <br> (0.71 to 1.02) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>930 participants, 930 interventions<br> (3 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>b,c,d</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported (estimated to be &lt; 1 hour)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>940 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>799 per 1000</b><br> (667 to 959) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>HeftâParker VAS (0â170 millimetres)</p> <p>Followâup: 0â1 minute following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86 participants, 172 interventions (1 study)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>HeftâParker VAS (0â170 millimetres)</p> <p>Followâup: measured at the time anaesthesia wore off</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86 participants, 172 interventions (1 study)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study. Exact time of followâup not reported</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: 0â24 hours</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63 participants, 187 interventions (1 study)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 case of urticaria occurred â unclear which local anaesthetic this occurred with</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear risk of attrition bias in one trial; unclear risks of selection bias in two trials).<br><sup>c</sup>Downgraded one level owing to inconsistency (substantial, unexplained heterogeneity).<br><sup>d</sup>Downgraded one level owing to imprecision (95% CI includes no effect and an appreciable benefit for 4% articaine, 1:100,000 epinephrine) </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span>Â <span class="table-title">4% prilocaine plain compared with 2% lidocaine 1:100, 000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>4% prilocaine plain compared with 2% lidocaine 1:100, 000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> private practice and a hospital setting in USA<br><b>Intervention:</b> 4% prilocaine plain<br><b>Comparison:</b> 2% lidocaine 1:100, 000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% lidocaine 1:100, 000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% prilocaine plain</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain ("complete anaesthesia")<br> Followâup: 5â30 minutes </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.86</b> <br> (0.75 to 0.99) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>228 participants, 228 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup reported only for bone study</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>828 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>712 per 1000</b><br> (621 to 820) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS</p> <p>Followâup: See comment</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>1 case of prolonged anaesthesia recorded</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0 participants (0 studies)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No clinical studies met outcome definition Unable to confirm if prolonged anaesthesia = paraesthesia and how long this lasted </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear methods of randomization sequence generation and allocation concealment).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span>Â <span class="table-title">4% articaine, 1:200,000 epinephrine compared with 0.5% bupivacaine, 1:200,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>4% articaine, 1:200,000 epinephrine compared with 0.5% bupivacaine, 1:200,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies where dental local anaesthesia was tested<br><b>Settings:</b> university departments in Spain (n = 2) and USA (n = 1; pain on injection)<br><b>Intervention:</b> 4% articaine, 1:200,000 epinephrine<br><b>Comparison:</b> 0.5% bupivacaine, 1:200,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>0.5% bupivacaine, 1:200,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% articaine, 1:200,000 epinephrine</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain<br> Followâup: from 10 minutes post injection to the end of the clinical procedure </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>OR 0.87</b> <br> (0.27 to 2.83) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>37 participants, 74 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported for both studies (estimated to be<br> &lt; 1 hour) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>481 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>446 per 1000</b><br> (200 to 724) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS. scale of 0â100</p> <p>Followâup: 0â30 seconds following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18 participants, 36 interventions (1 study)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study. Unclear whether data relate to just solution deposition. Standand deviations not reported </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; OR = odds ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (trials had unclear or high risk of bias related to methods of randomization sequence generation and allocation concealment, and one study had high risk of bias for blinding of participants and personnel and incomplete outcome data (high attrition rate of 46%)).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size, and 95% confidence interval includes no effect and an appreciable benefit for both solutions). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0006"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 6.</span>Â <span class="table-title">0.5% bupivacaine, 1:200,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>0.5% bupivacaine, 1:200,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Australia (n = 1) and USA (n = 3, including speed of onset (1) and pain on injection (1))<br><b>Intervention:</b> 0.5% bupivacaine, 1:200,000 epinephrine<br><b>Comparison:</b> 2% lidocaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% lidocaine, 1:100,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>0.5% bupivacaine, 1:200,000 epinephrine</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale (VAS) or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain<br> Followâup: from 10 minutes post injection to the end of the clinical procedure </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>OR 0.58</b> <br> (0.07 to 5.12) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>31 participants, 62 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported for both studies (estimated to be<br> &lt; 1 hour) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>611 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>477 per 1000</b><br> (99 to 889) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: See comment </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100 participants, 100 interventions (1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study. Duration of followâup not reported</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS. scale of 0â100</p> <p>Followâup: 0â30 seconds following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18 participants, 36 interventions (1 studies)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study. Unclear whether data relate to just solution deposition. Standand deviations not reported </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; OR = odds ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear methods of randomization sequence generation).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size, and 95% confidence interval includes no effect and an appreciable benefit for both solutions). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0007"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 7.</span>Â <span class="table-title">4% articaine, 1:100,000 epinephrine compared with 2% mepivacaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>4% articaine, 1:100,000 epinephrine compared with 2% mepivacaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Brazil (n = 1), Saudi Arabia (n = 1), and Thailand (n = 1)<br><b>Intervention:</b> 4% articaine, 1:100,000 epinephrine<br><b>Comparison:</b> 2% mepivacaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% mepivacaine, 1:100,000 epinephrine</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4% articaine, 1:100,000 epinephrine </b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of healthy pulps, hard and soft tissues)</b><br> Absence of pain<br> Followâup: 10â20 minutes </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>OR 3.82</b> <br> (0.61 to 23.82) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>110 participants, 130 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>931 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>996 per 1000</b><br> (912 to 1000) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS. scale of 0â100</p> <p>Followâup: 0â40 seconds and 0â60 seconds following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>147 participants, 147 interventions (2 studies)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear whether data relate to just solution deposition in both studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to study limitations (unclear risks of bias (methods of randomization sequence generation, allocation concealment, blinding of participants and personnel, and blinding of outcome assessors)).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006487-tbl-0008"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 8.</span>Â <span class="table-title">2% mepivacaine, 1:100,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>2% mepivacaine, 1:100,000 epinephrine compared with 2% lidocaine, 1:100,000 epinephrine for dental anaesthesia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> participants regardless of age and gender who were undergoing dental procedures and volunteers who took part in simulated scenario studies in which dental local anaesthesia was tested<br><b>Settings:</b> university departments in Brazil (n = 2) and Saudi Arabia (n = 1)<br><b>Intervention:</b> 2% mepivacaine, 1:100,000 epinephrine<br><b>Comparison:</b> 2% lidocaine, 1:100,000 epinephrine </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% lidocaine, 1:100,000 epinephrine </b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>2% mepivacaine, 1:100,000 epinephrine</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Success of local anaesthesia, measured by the absence of pain during a procedure using a visual analogue scale or other appropriate method (clinical testing of diseased pulps with irreversible pulpitis)</b><br> Absence of pain<br> Followâup: from 10 minutes or 14 minutes post injection to the end of the clinical procedure </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.16</b> <br> (0.25 to 5.45) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>68 participants, 68 interventions<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of followâup not reported (estimated to be<br> &lt; 1 hour) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>231 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>268 per 1000</b><br> (58 to 1000) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Speed of onset of anaesthesia</b> </p> <p>Time from injection to complete anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Duration of anaesthesia</b> </p> <p>Time from onset of anaesthesia to loss of anaesthesia, measured in minutes<br> Followâup: not applicable </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain on injection (solution deposition)</b> </p> <p>VAS. scale of 0â100</p> <p>Followâup: 0â1 minute following needle insertion</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48 participants, 48 interventions (1 study)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Orphan study. Unclear whether data relate to just solution deposition</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: pain following injection</b> </p> <p>VAS</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: paraesthesia following injection</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects: allergy to local anaesthetic</b> </p> <p>Number of participants</p> <p>Followâup: not applicable</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; VAS = visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Little variation in baseline risks across studies.<br><sup>b</sup>Downgraded one level owing to inconsistency (wide variation in point estimates and substantial unexplained heterogeneity).<br><sup>c</sup>Downgraded one level owing to imprecision (small total sample size, and 95% CI includes no effect and an appreciable benefit for both solutions). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
